Immuneering (IMRX) Intangibles (2021 - 2026)
Immuneering (IMRX) posted quarterly Intangibles of $313830.0 for Q1 2026, down 8.53% year-over-year from $343097.0 in Q1 2025, and down 2.28% quarter-over-quarter from $321147.0 in Q4 2025.
Powered by 
Analysis
Immuneering (IMRX) Intangibles (2021 - 2026) Analysis & Trends
Immuneering's Intangibles history runs 6 years deep, the most recent figure standing at $313830.0 for Q1 2026.
- In Q1 2026, Intangibles fell 8.53% year-over-year to $313830.0; the TTM figure through Mar 2026 stood at $313830.0 (down 8.53% YoY), while the FY2025 annual figure was $321147.0, down 8.35% from the prior year.
- Intangibles for Q1 2026 stood at $313830.0, down from $321147.0 in the prior quarter.
- The five-year high for Intangibles was $430897.0 in Q1 2022, with the low at $313830.0 in Q1 2026.
- The 5-year median for Intangibles is $372363.0 (2024), against an average of $372363.4.
- The sharpest annual moves came in 2023 and 2026: Intangibles dropped 6.79% in 2023, then fell 8.53% in 2026.
- Immuneering's Intangibles stood at $408947.0 in 2022, then decreased by 7.16% to $379680.0 in 2023, then dropped by 7.71% to $350413.0 in 2024, then fell by 8.35% to $321147.0 in 2025, then declined by 2.28% to $313830.0 in 2026.
- Business Quant data shows IMRX's Intangibles at $313830.0 in Q1 2026, $321147.0 in Q4 2025, and $328463.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 63.28 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 60.96 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Immuneering | 316.05 Mn | 316.05 Mn | - | 306,513.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 306,513.00 |
| Mar 31, 2026 | 313,830.00 |
| Dec 31, 2025 | 321,147.00 |
| Sep 30, 2025 | 328,463.00 |
| Jun 30, 2025 | 335,780.00 |
| Mar 31, 2025 | 343,097.00 |
| Dec 31, 2024 | 350,413.00 |
| Sep 30, 2024 | 357,730.00 |
| Jun 30, 2024 | 365,047.00 |
| Mar 31, 2024 | 372,363.00 |
| Dec 31, 2023 | 379,680.00 |
| Sep 30, 2023 | 386,997.00 |
| Jun 30, 2023 | 394,313.00 |
| Mar 31, 2023 | 401,630.00 |
| Dec 31, 2022 | 408,947.00 |
| Sep 30, 2022 | 416,263.00 |
| Jun 30, 2022 | 423,580.00 |
| Mar 31, 2022 | 430,897.00 |
| Dec 31, 2021 | 439,000.00 |